Use of omalizumab is associated with improvement of pruritic skin disorders induced by immune checkpoint inhibitors: A retrospective cohort from the European Task Force of Dermatology for Cancer patients.
作者信息
Alamon-Reig Francesc, Bosch-Amate Xavier, Giavedoni Priscila, Nikolaou Vasiliki, Mangas Cristina, Apalla Zoe, Mayor Ander, Oikonomou Chrysa, Starace Michela, Sibaud Vincent, Carrera Cristina
机构信息
Department of Dermatology, Hospital Clínic de Barcelona, FRCB, Universitat de Barcelona, Barcelona, Spain.
DermatoOncology Department, Andreas Sygros Hospital, University of Athens, Athens, Greece.
出版信息
J Am Acad Dermatol. 2024 Feb;90(2):429-432. doi: 10.1016/j.jaad.2023.10.012. Epub 2023 Oct 14.
PMID:37844688
Abstract
摘要
Zotero 插件